Skip to main content
Print Save

TEVA 5346 (Methylphenidate Hydrochloride Extended-Release (LA) 20 mg)

Pill with imprint TEVA 5346 is White, Capsule-shape and has been identified as Methylphenidate Hydrochloride Extended-Release (LA) 20 mg. It is supplied by Teva Pharmaceuticals USA Inc.

Methylphenidate is used in the treatment of adhd; narcolepsy; depression and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Methylphenidate 20 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for TEVA 5346

Methylphenidate hydrochloride extended-release (LA) 20 mg TEVA 5346

Methylphenidate Hydrochloride Extended-Release (LA)

Imprint
TEVA 5346
Strength
20 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
CNS stimulants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
2 - High potential for abuse
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5346
Inactive Ingredients
ammonio methacrylate copolymer type B, ferrosoferric oxide, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Blue No. 2, FD&C Red No. 40, hypromellose 2208 (3 mPa.s), methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol 6000, propylene glycol, shellac, corn starch, sucrose, magnesium silicate, titanium dioxide, triethyl citrate

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer